Finanzen von CME Group Inc (CME)CMECME Group Inc

Evaluating the bottom line, CME Group Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 81.11%, while the net margin is 32.86%. These profitability ratios, combined with a Return on Equity (ROE) of 16.08%, provide a clear picture of how effectively CME converts its operational activities into shareholder value.

In the context of the broader market, CME competes directly with industry leaders such as BNY and ICE. With a market capitalization of $105.55B, it holds a leading position in the sector. When comparing efficiency, CME's gross margin of N/A stands against BNY's N/A and ICE's N/A. Such benchmarking helps identify whether CME Group Inc. is trading at a premium or discount relative to its financial performance.

CME Group has shown consistent revenue growth, with nearly $6.5 billion in revenue for fiscal 2025, reflecting a 6.4% increase. The net margin stands at a strong 62%, demonstrating high profitability. The forward P/E ratio is 21.93, indicating reasonable valuation relative to expected earnings growth.